(Q34169310)

English

Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

0 references

Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer. (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

chemoradiotherapy

0 references

0 references

systematic review

1 reference

based on heuristic

inferred from title

author name string

S T Martin

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

H M Heneghan

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

D C Winter

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

language of work or name

0 references

publication date

23 February 2012

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

British Journal of Surgery

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

99

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

918-928

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Preoperative versus postoperative chemoradiotherapy for rectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial.

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Long-term oncologic results and complications after preoperative chemoradiotherapy for rectal cancer: a single-institution experience after a median follow-up of 95 months.

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial.

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Optimal timing of surgery after chemoradiation for advanced rectal cancer: preliminary results of a multicenter, nonrandomized phase II prospective trial

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Clinical significance of acellular mucin in rectal adenocarcinoma patients with a pathologic complete response to preoperative chemoradiation.

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Predicting the node-negative mesorectum after preoperative chemoradiation for locally advanced rectal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients.

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Complete pathologic response after preoperative rectal cancer chemoradiotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Preoperative chemoradiation with irinotecan and capecitabine in patients with locally advanced resectable rectal cancer: long-term results of a Phase II study.

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome.

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03.

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Preoperative chemoradiation for rectal cancer: results of multimodality management and analysis of prognostic factors.

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Infusional 5-fluorouracil and ZD1839 (Gefitinib-Iressa) in combination with preoperative radiotherapy in patients with locally advanced rectal cancer: a phase I and II Trial (1839IL/0092).

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Pathologic complete response of primary tumor following preoperative chemoradiotherapy for locally advanced rectal cancer: long-term outcomes and prognostic significance of pathologic nodal status (KROG 09-01).

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Recurrence and survival after total mesorectal excision for rectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Canc

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Pattern of recurrence in rectal carcinoma: implications for the design of (future) studies on adjuvant therapy

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Curative potential of multimodality therapy for locally recurrent rectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Complete response to neoadjuvant chemoradiation for rectal cancer does not influence survival

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012.

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Molecular response to cetuximab and efficacy of preoperative cetuximab-based chemoradiation in rectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Local excision after preoperative chemoradiation results in an equivalent outcome to total mesorectal excision in selected patients with T3 rectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Transanal excision of locally advanced rectal cancers downstaged using neoadjuvant chemoradiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Long-term results in patients with T2-3 N0 distal rectal cancer undergoing radiotherapy before transanal endoscopic microsurgery.

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Downstaging after chemoradiotherapy for locally advanced rectal cancer: is there more (tumor) than meets the eye?

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Neoadjuvant therapy for rectal cancer: histologic response of the primary tumor predicts nodal status

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Preoperative chemoradiotherapy with oral doxifluridine plus low-dose oral leucovorin in unresectable primary rectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excisi

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FBJS.8702

21 January 2018

Identifiers

10.1002/BJS.8702

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34169310&oldid=1474021456"